4.5 Article Publication with Expression of Concern

Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma (Publication with Expression of Concern. See vol. 123, 2021)

Related references

Note: Only part of the references are listed.
Article Cell Biology

m6A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer

Lei Xue et al.

Summary: In NSCLC, lncRNA ABHD11-AS1 is upregulated and promotes proliferation and the Warburg effect. METTL3 enhances ABHD11-AS1 transcript stability to increase its expression.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Review Biochemistry & Molecular Biology

Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA

Pan Wu et al.

MOLECULAR CANCER (2020)

Article Biochemistry & Molecular Biology

LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy

Sergey D. Egranov et al.

RNA BIOLOGY (2020)

Review Medicine, Research & Experimental

Serum biomarkers for thyroid cancer

Qian Xiao et al.

BIOMARKERS IN MEDICINE (2020)

Article Biochemistry & Molecular Biology

LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis

NingHeng Chen et al.

BIOSCIENCE REPORTS (2019)

Article Biochemistry & Molecular Biology

HOXD-AS1 is a predictor of clinical progression and functions as an oncogenic lncRNAs in papillary thyroid cancer

Kai Xu et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Cell Biology

LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1

Yao Liu et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

Article Biochemistry & Molecular Biology

Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme

Sze Kiat Tan et al.

MOLECULAR CANCER (2018)

Article Oncology

MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer

Lei Dai et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)